Pharma Max

BiotechnologySeries BTaizhou, Chinapharmamaxcorp.com

Latest round

Series B

Last raised

Sep 2021

Total raised

Undisclosed

Investors

5

About Pharma Max

Based in Jiangsu, China and founded in 2010, Pharma Max is a developer of oronasal drugs, focusing on the research and development, production and sales of new drugs and medical devices. The company has established a research and development and production platform for liquid preparations, solid preparations, microspheres and liposomes. The founder, chairman of board and president Dr. Zhijun Jiang, he has been engaged in bio-pharmaceutical innovation research for more than 30 years, he served as vice president of research and development and operation of Teva. The company's medical device products Bi Min Ling, Sai Li Ping, Gan Qing have been approved for listing.

Who invested in Pharma Max

5 investors across 2 rounds

See all investors in Pharma Max

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 8, 2021

    Amount

    Undisclosed

    Investors

    Locked

  2. Series B

    Apr 17, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Pharma Max

Who invested in Pharma Max?

Pharma Max has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Pharma Max raised?

Pharma Max has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Pharma Max last raise money?

Pharma Max's most recent round on record is a Series B, in Sep 2021.

What does Pharma Max do?

Based in Jiangsu, China and founded in 2010, Pharma Max is a developer of oronasal drugs, focusing on the research and development, production and sales of new drugs and medical devices.

Where is Pharma Max headquartered?

Pharma Max is headquartered in Taizhou, China.

Which VCs invest in companies like Pharma Max?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Pharma Max's stage. Their profiles are linked below.

Raising like Pharma Max? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.